Q1 FY2023 · Presentation
Novo Nordisk - Investor Update - Conference Call Deck · 48 pages
Read Novo Nordisk A/S Class B's results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional